Milk‐Derived Kefir Improves Cardiac Function in Female Rats Subjected to Myocardial Infarction
Journal of Nutrition and Metabolism · 2026-01 · 2026 (1)
DOI: 10.1155/jnme/9655398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nutrition and Metabolism, online erschienen am 12.08.2026. Verfasst von Ávila Iglesias Caliari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Vila Velha University-UVV, Vila Velha, Espírito Santo, Brazil. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Amapá, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Cardiovascular diseases remain a major global health burden, with myocardial infarction (MI) being a leading cause of mortality and long‐term disability. Kefir, a fermented milk beverage rich in probiotic and bioactive compounds, has demonstrated cardioprotective effects in experimental models of hypertension. However, its effects in MI induced by coronary artery ligation remain poorly understood. This study investigated the impact of chronic kefir administration on cardiac function and remodeling in female Wistar rats subjected to MI. Animals were allocated to three groups: sham‐operated (S), infarct vehicle‐treated (IV), and infarct kefir‐treated (IK). Treatments were administered daily for 60 days. Hemodynamic parameters, infarct area, collagen deposition, oxidative stress markers, and morphometric changes were evaluated. Chronic kefir treatment significantly reduced left ventricular end‐diastolic pressure (LVEDP), infarct area, and collagen deposition in infarcted animals. Kefir also improved hemodynamic parameters by reducing systolic, diastolic, and mean arterial pressures while increasing heart rate. In addition, oxidative stress was attenuated, as evidenced by lower levels of advanced oxidation protein products (AOPP). No evidence of systemic toxicity or organ hypertrophy was observed. These findings suggest that milk‐derived kefir exerts cardioprotective effects by improving hemodynamic function, attenuating adverse cardiac remodeling, and reducing oxidative stress. Collectively, the results support the potential of kefir as an adjunctive strategy for improving cardiac recovery following MI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Vila Velha University-UVV, Vila Velha, Espírito Santo, Brazil.
- Department of Physiology and Pharmacology, Health Sciences Center, Federal University of Espírito Santo-UFES, Vitória, Espírito Santo, Brazil.
ORCID-Profile: Ávila Iglesias Caliari, Juarez Henrique Ferreira, Licia Cristina Silva de Lima Oliveira, Tadeu Uggere de Andrade, Ewelyne Miranda de Lima, Girlandia Alexandre Brasil
Förderung
- Fundação de Amparo à Pesquisa do Amapá
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Caliari, Á. I., Ferreira, J. H., Oliveira, L. C. S. L., de Andrade, T. U., de Lima, E. M., de Almeida, S. A., & Brasil, G. A. (2026). Milk‐Derived Kefir Improves Cardiac Function in Female Rats Subjected to Myocardial Infarction. Journal of Nutrition and Metabolism, 2026(1). https://doi.org/10.1155/jnme/9655398
Vancouver
Caliari ÁI, Ferreira JH, Oliveira LCSL, de Andrade TU, de Lima EM, de Almeida SA, et al. Milk‐Derived Kefir Improves Cardiac Function in Female Rats Subjected to Myocardial Infarction. Journal of Nutrition and Metabolism. 2026;2026(1). doi:10.1155/jnme/9655398
BibTeX
@article{Caliari2026,
author = {Caliari, Ávila Iglesias and Ferreira, Juarez Henrique and Oliveira, Licia Cristina Silva de Lima and de Andrade, Tadeu Uggere and de Lima, Ewelyne Miranda and de Almeida, Simone Alves and Brasil, Girlandia Alexandre},
title = {Milk‐Derived Kefir Improves Cardiac Function in Female Rats Subjected to Myocardial Infarction},
journal = {Journal of Nutrition and Metabolism},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jnme/9655398}
}
EUVIMED